| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (13件)
- Hiromi Hagiwara, Takafumi Nakayama, Hiroya Hashimoto, Shigeru Kusumoto, Hidekatsu Fukuta, Takeshi Kamiya, Koichi Ikuta, Shinsuke Iida. Risk factors associated with overall survival in multiple myeloma patients following carfilzomib treat ment: A retrospective study from a large claims database in Japan. CANCER MEDICINE. 2023. 12. 19. 19361-19371
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials. IJC Heart & Vasculature. 2022. 42. 101103-101103
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in heart failure patients: A protocol for systematic review and meta-analysis. PLOS ONE. 2022. 17. 9. e0275311-e0275311
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Influenza vaccination in patients with heart failure. Medicine. 2022. 101. 6. e28844-e28844
- Takeshi Kamiya, Hidekatsu Fukuta, Hiromi Hagiwara, Michiko Shikano, Takashi Kato, Kenro Imaeda. Disturbed gastric motility in patients with long-standing diabetes mellitus. Journal of Smooth Muscle Research. 2022. 58. 1-10
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. Medicine. 2021. 100. 51. e28448-e28448
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Effects of angiotensin-receptor neprilysin inhibitor on exercise capacity, quality of life, and cardiac function in heart failure with preserved ejection fraction. Medicine: Case Reports and Study Protocols. 2021. 2. 10. e0160-e0160
- Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Iron therapy in iron-deficiency patients with heart failure with preserved ejection fraction. Medicine. 2021. 100. 32. e26919-e26919
- Hiromi Hagiwara, Hidekatsu Fukuta, Hiroya Hashimoto, Takahiro Niimura, Yoshito Zamami, Keisuke Ishizawa, Takeshi Kamiya, Nobuyuki Ohte. A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database. Journal of Cardiology. 2020. 77. 3. 285-291
- Hiromi Hagiwara, Hidekatsu Fukuta, Takahiro Niimura, Yoshito Zamami, Keisuke Ishizawa, Kazunori Kimura, Takeshi Kamiya, Nobuyuki Ohte. Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases. International Journal of Medical Sciences. 2020. 17. 6. 728-733
- Yoshito Zamami, Takahiro Niimura, Toshihiro Koyama, Yuta Shigemi, Yuki Izawa-Ishizawa, Mizuki Morita, Ayako Ohshima, Keisaku Harada, Toru Imai, Hiromi Hagiwara, et al. Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database. Frontiers in Pharmacology. 2019. 10. 1257-1257
- Hagiwara Hiromi, Nishikawa Ryouhei, Fukuzawa Kazuki, Tohkin Masahiro. The Survey of the Compliance Situation to the Antihypertensive Therapy Guideline by Analyzing Japanese National Claims Data. 薬学雑誌. 2017. 137. 7. 893-901
- Hiromi Hagiwara, Shun Nakano, Yoshihiro Ogawa, Masahiro Tohkin. The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data. Journal of Clinical Pharmacy and Therapeutics. 2015. 40. 3. 273-278
1〜13 件目 / 全 13 件
- « 最初
- ‹ 前へ
- 1
- 次へ ›
- 最後 »
